The role of stents in hemodialysis vascular access

Aisha Shaikh1, Alian Albalas2, Brinda Desiraju3

  • 1Department of Medicine, James J. Peters VA Medical Center, Bronx, NY, USA.

Insights

Vascular access stenosis is a common complication in end-stage kidney disease patients undergoing dialysis. Stents offer a promising solution to improve vascular access patency, overcoming limitations of traditional balloon angioplasty.

Area of Science:

  • Nephrology and Vascular Surgery
  • Dialysis Vascular Access Management
  • Interventional Radiology

Background:

  • Vascular access complications, particularly neointimal hyperplasia and stenosis, significantly impact dialysis therapy for end-stage kidney disease (ESKD) patients.
  • Traditional percutaneous transluminal angioplasty (PTA) using balloon inflation has shown suboptimal patency rates for these stenotic lesions.
  • The limitations of balloon angioplasty necessitate the exploration of advanced interventions to enhance vascular access functionality.

Purpose of the Study:

  • To review the existing literature on the efficacy of stents in managing stenotic lesions within dialysis vascular access.
  • To analyze major clinical trials evaluating stent use across various anatomical locations and clinical scenarios in dialysis patients.
  • To provide an overview of current evidence regarding stent-based interventions for dialysis vascular access stenosis.

Main Methods:

  • Comprehensive literature search of available studies on stent utilization for dialysis vascular access stenosis.
  • Review and synthesis of data from major clinical trials focusing on different stent types and applications.
  • Analysis of outcomes related to vascular access patency and clinical efficacy in diverse patient populations.

Main Results:

  • Stent-based interventions have emerged as a significant advancement over traditional balloon angioplasty for treating dialysis vascular access stenosis.
  • Evidence from clinical trials suggests improved patency rates and functional outcomes with stent use in various anatomical locations.
  • The effectiveness of stents may vary depending on the specific type of stent, lesion characteristics, and clinical context.

Conclusions:

  • Stent placement represents a valuable therapeutic option for managing neointimal hyperplasia and stenosis in dialysis vascular access.
  • Further research and comparative studies are warranted to optimize stent selection and application strategies for improved long-term outcomes.
  • Stents hold the potential to significantly enhance the durability and functionality of vascular access, thereby improving the quality of life for dialysis patients.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
567
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
252
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
357
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
798
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.1K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
73